Widely used as a chiral ligand in asymmetric catalysis, this compound plays a key role in enantioselective organic transformations. It forms complexes with transition metals such as rhodium, ruthenium, and iridium, which are highly effective in asymmetric hydrogenation reactions. These reactions are critical in the pharmaceutical industry for producing single-enantiomer compounds, especially in the synthesis of chiral intermediates for drugs. Its rigid aromatic backbone and stereogenic oxazoline rings enhance stereocontrol, leading to high enantiomeric excess in products. It is also employed in the development of catalysts for carbon-carbon bond-forming reactions, contributing to efficient and selective synthetic routes in fine chemical manufacturing.